204 related articles for article (PubMed ID: 25511754)
1. Repetitive immunoadsorption cycles for treatment of severe atopic dermatitis.
Daeschlein G; Scholz S; Lutze S; Eming R; Arnold A; Haase H; Hertl M; Jünger M
Ther Apher Dial; 2015 Jun; 19(3):279-87. PubMed ID: 25511754
[TBL] [Abstract][Full Text] [Related]
2. Single-use IgE-selective immunoadsorber column for the treatment of severe atopic dermatitis.
Meyersburg D; Laimer M; Kugler A; Mühlthaler E; Lindlbauer N; Hitzl W; Rohde E; Bauer JW; Grabmer C
J Clin Apher; 2020 Jan; 35(1):50-58. PubMed ID: 31755575
[TBL] [Abstract][Full Text] [Related]
3. Immunoadsorption for treatment of severe atopic dermatitis.
Wegner J; Weinmann-Menke J; von Stebut E
Atheroscler Suppl; 2017 Nov; 30():264-270. PubMed ID: 29096848
[TBL] [Abstract][Full Text] [Related]
4. IgE-Selective Immunoadsorption for Severe Atopic Dermatitis.
Kasperkiewicz M; Mook SC; Knuth-Rehr D; Vorobyev A; Ludwig RJ; Zillikens D; Muck P; Schmidt E
Front Med (Lausanne); 2018; 5():27. PubMed ID: 29484297
[TBL] [Abstract][Full Text] [Related]
5. Targeting IgE in Severe Atopic Dermatitis with a Combination of Immunoadsorption and Omalizumab.
Zink A; Gensbaur A; Zirbs M; Seifert F; Suarez IL; Mourantchanian V; Weidinger S; Mempel M; Ring J; Ollert M
Acta Derm Venereol; 2016 Jan; 96(1):72-6. PubMed ID: 26059424
[TBL] [Abstract][Full Text] [Related]
6. Synbiotics could not reduce the scoring of childhood atopic dermatitis (SCORAD): a randomized double blind placebo-controlled trial.
Shafiei A; Moin M; Pourpak Z; Gharagozlou M; Aghamohammadi A; Sajedi V; soheili H; Sotoodeh S; Movahedi M
Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):21-8. PubMed ID: 21358011
[TBL] [Abstract][Full Text] [Related]
7. Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis.
Kasperkiewicz M; Schmidt E; Ludwig RJ; Zillikens D
Front Immunol; 2018; 9():254. PubMed ID: 29520268
[TBL] [Abstract][Full Text] [Related]
8. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
9. Relationship between serum levels of interleukin-18, IgE and disease severity in patients with atopic dermatitis.
Trzeciak M; Gleń J; Bandurski T; Sokołowska-Wojdyło M; Wilkowska A; Roszkiewicz J
Clin Exp Dermatol; 2011 Oct; 36(7):728-32. PubMed ID: 21689145
[TBL] [Abstract][Full Text] [Related]
10. Effects of Intramuscular Injection of Autologous Immunoglobulin on Clinical Severity and Serum IgE Concentration in Patients with Atopic Dermatitis.
Nahm DH; Kim ME; Cho SM
Dermatology; 2015; 231(2):145-51. PubMed ID: 26112673
[TBL] [Abstract][Full Text] [Related]
11. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
12. IgE-specific immunoadsorption for treatment of recalcitrant atopic dermatitis.
Kasperkiewicz M; Süfke S; Schmidt E; Zillikens D
JAMA Dermatol; 2014 Dec; 150(12):1350-1. PubMed ID: 25271706
[No Abstract] [Full Text] [Related]
13. Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis.
Kou K; Aihara M; Matsunaga T; Chen H; Taguri M; Morita S; Fujita H; Yamaguchi Y; Kambara T; Ikezawa Z
Arch Dermatol Res; 2012 May; 304(4):305-12. PubMed ID: 22146836
[TBL] [Abstract][Full Text] [Related]
14. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure.
Wang IJ; Wang JY
Clin Exp Allergy; 2015 Apr; 45(4):779-87. PubMed ID: 25600169
[TBL] [Abstract][Full Text] [Related]
15. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
[TBL] [Abstract][Full Text] [Related]
16. An association of TLR2–16934A >T polymorphism and severity/phenotype of atopic dermatitis.
Potaczek DP; Nastalek M; Okumura K; Wojas-Pelc A; Undas A; Nishiyama C
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):715-21. PubMed ID: 21134221
[TBL] [Abstract][Full Text] [Related]
17. Specific IgE of common foods in Chinese children with eczema.
Hon KL; Chan IH; Chow CM; Wang SS; Lam CW; Ng PC; Leung TF
Pediatr Allergy Immunol; 2011 Feb; 22(1 Pt 1):50-3. PubMed ID: 20609136
[TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study.
Cadario G; Galluccio AG; Pezza M; Appino A; Milani M; Pecora S; Mastrandrea F
Curr Med Res Opin; 2007 Oct; 23(10):2503-6. PubMed ID: 17784996
[TBL] [Abstract][Full Text] [Related]
19. Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis.
Gerdes S; Kurrat W; Mrowietz U
Br J Dermatol; 2009 Apr; 160(4):736-40. PubMed ID: 19076976
[TBL] [Abstract][Full Text] [Related]
20. Effect of Cluster Allergen-Specific Immunotherapy in Patients with Atopic Dermatitis Sensitive to House Dust Mite.
Elazab SZ; Hessam WF; Gomaa AH
Egypt J Immunol; 2018 Jun; 25(2):97-106. PubMed ID: 30600952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
